Complexities of Targeting HER2 in Estrogen Receptor–Positive Breast Cancers - The ASCO Post - Her2 estrogen positive breast cancer
- Views: 527 554
Breast cancers are ER-positive, HER2-positive, or triple negative. The type of breast cancer you have determines the type of medication you. The interactions between the estrogen receptor (ER) and HER2 pathways in breast cancers are clearly complex and remain incompletely.